<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04212988</url>
  </required_header>
  <id_info>
    <org_study_id>XJTU1AF-CRF-2017-009</org_study_id>
    <nct_id>NCT04212988</nct_id>
  </id_info>
  <brief_title>Effect of Cerebral Oxygen Saturation Intervention</brief_title>
  <acronym>ECOS</acronym>
  <official_title>Effect of Cerebral Oxygen Saturation Interventionon Postoperative Delirium After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative delirium (POD) is a common complication after cardiac surgery,and the&#xD;
      pathogenesis is considered imbalance of cerebral oxygen. It may induce the POD incidence by&#xD;
      monitering and intervening the low cerebral oxygen desaturation(SCO2) in cardiac surgery&#xD;
      .Near infrared spectroscopy (NIRS) will be used for monitering the cerebral oxygen levels.140&#xD;
      case will be included and divided in to trial and control group. The primary outcome is POD&#xD;
      In 72 hours after the surgery , which is assessed according to delirium scale .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative delirium (POD) is a common complication after cardiac surgery. Imbalance of&#xD;
      cerebral oxygen supply and demand is one of the pathogenesis of postoperative delirium. The&#xD;
      perioperative cerebral oxygen levels and postoperative delirium highly correlated, while as a&#xD;
      high incidence of cerebral oxygen desaturation(SCO2) in cardiac surgery, especially in&#xD;
      extracorporeal circulation. Near infrared spectroscopy (NIRS) can monitor the SCO2&#xD;
      continuously, noninvasively, simultaneously on bilateral cerebral hemisphere, and monitoring&#xD;
      will not restricted by extracorporeal circulation.Using NIRS to moniter and intervene&#xD;
      thecerebral oxygen levels in extracorporeal circulation of heart surgery patients ,thereby&#xD;
      reducing the incidence of postoperative delirium. This hypothesis has a very important&#xD;
      clinical value.&#xD;
&#xD;
      This study intends to include 140 patients, who requires extracorporeal circulation cardiac&#xD;
      surgical treatment. All cases will be divided into trial group and control group preoperative&#xD;
      follow-up.Two groups of patients in surgery will be both performed the investigator's&#xD;
      existing standerd monitoring and surgery process.&#xD;
&#xD;
      The trial group cases will be given NIRS monitoring in the whole surgical procedure. And once&#xD;
      the SCO2 value below ideal levels (80% of the basic level or 50% of the absolute value), the&#xD;
      intervention process will be started immediately to correct the low cerebral oxygen status,&#xD;
      by adjusting the position of extracorporeal circulation arteriovenous catheter, stabilizing&#xD;
      the mean arterial pressure, increasing oxygen supply and , adjusting the pump speed, etc. The&#xD;
      control group cases will be only placed the probe of NIRS moniter.&#xD;
&#xD;
      In 72 hours after the surgery , all patients will be assessed POD by cardiac surgery&#xD;
      intensivecare unit(CICU) physicians according to delirium scale .&#xD;
&#xD;
      This project intends to research monitoring brain oxygen supply and intervention can reduce&#xD;
      the incidence of postoperative delirium.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>single blind</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of POD</measure>
    <time_frame>3 days after sugery</time_frame>
    <description>the incidence of postoperative delirium in the cases after 3 days after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>the trial group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The interwention process will be started once the SCO2 value below ideal levels (80% of the basic level or 50% of absolute value), by adjusting the position of extracorporeal circulation arteriovenous catheter, balancing arterial pressure, increasing oxygen supply , adjusting pump speed ,etc.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In control group patients, only place the probe for NIRS monitor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Increase the SCO2 value</intervention_name>
    <description>The interwention process will be started once the SCO2 value below ideal levels (80% of the basic level or 50% of absolute value), by adjusting the position of extracorporeal circulation arteriovenous catheter, balancing arterial pressure, increasing oxygen supply , adjusting pump speed ,etc.</description>
    <arm_group_label>the control group</arm_group_label>
    <arm_group_label>the trial group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Participate and sign the informed consent voluntary;&#xD;
&#xD;
          2. Over 18 years of age;&#xD;
&#xD;
          3. Who recieve the heart surgery under extracorporeal circulation;&#xD;
&#xD;
          4. Able to communicate and abey the experimental requirements well .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Refused to sign a consent form;&#xD;
&#xD;
          2. Less than 18 years of age;&#xD;
&#xD;
          3. With history of nervous, mental, and cerebrovascular disease;&#xD;
&#xD;
          4. With history of alcohol or apsychiatric drug addiction;&#xD;
&#xD;
          5. Can't cooperate the evaluation: dementia, dysaudia, visually impaired , etc;&#xD;
&#xD;
          6. Critically diseases: severe liver and kidney dysfunction, cardiac shock or IABP&#xD;
             placement status.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>FirstXianJiaotongU</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 25, 2019</study_first_submitted>
  <study_first_submitted_qc>December 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2019</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

